Letrozole ≥98%|CAS:112809-51-5|25 mg|50 mg|100 mg

Femara |Letrozole is an inhibitor of aromatase that prevents the formation of estrogens; it is clinically used to treat hormone-responsive breast cancer and infertility and to terminate pregnancy. Letrozole exhibits anticancer chemotherapeutic and anti-estrogenic activities. In vivo, letrozole increases secretion of luteinizing hormone (LH), lengthens the follicular dominance period, and delays subsequent follicular waves.|C17H11N5|285.3||-20°C|Soluble in dichloromethane, DMSO (100 mM). Slightly soluble in ethanol. practically insoluble in water. Soluble in chloroform, methanol.